• Issue

    Biopharmaceutics & Drug Disposition: Volume 46, Issue 1

    1-46
    February 2025

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 1-2
  • First Published: 24 March 2025

ORIGINAL ARTICLE

In Vivo Animal Spices and Experimental Technique to Evaluate Sustained Release Granules

  • Pages: 3-9
  • First Published: 02 January 2025
In Vivo Animal Spices and Experimental Technique to Evaluate Sustained Release Granules

Propanteline bromide-treated (PBT) dog model would be useful to evaluate at least prototype enteric-coated granules in order to develop the human conscious clinical formulations, although normal dog model could not evaluate modified release formulations such as enteric-coated granules.

Nanostructured Lipid Carriers-Based Topical Gel of Betulinic Acid: In Vitro, In Vivo Evaluation and Dermatokinetic Analysis

  • Pages: 10-21
  • First Published: 04 March 2025
Nanostructured Lipid Carriers-Based Topical Gel of Betulinic Acid: In Vitro, In Vivo Evaluation and Dermatokinetic Analysis

The optimized betulinic acid-loaded nanostructured lipid carrier hydrogel offered nanometric size, controlled drug release, and greater permeation. The developed formulation can provide a better delivery option in substantial amounts to various skin layers.

An Optimised Mobilenet V2 Attention Parallel Network for Predicting Drug–Drug Interactions Through Combining Local and Global Features

  • Pages: 22-32
  • First Published: 12 March 2025
An Optimised Mobilenet V2 Attention Parallel Network for Predicting Drug–Drug Interactions Through Combining Local and Global Features

Drug–drug interactions (DDIs) pose significant risks to patient safety in clinical practice and drug development, making accurate prediction essential for effective medication management. This work introduces the MobileNetV2 with simplicial attention network based parallel convolutional neural network with narwhal optimizer (MV2SAPCN-NO) for DDI prediction. After preprocessing DDI datasets to eliminate noise, the model extracts local and global features using MobileNetV2 and simplicial attention. The parallel convolutional neural network is optimised with the narwhal optimiser to enhance accuracy and reduce computational complexity, outperforming existing methods based on accuracy, precision, recall and F-score metrics.

Pregnenolone Sulfate Permeation at the Blood–Brain Barrier is Independent of OATP2B1—In Vivo and In Vitro Insights

  • Pages: 33-46
  • First Published: 12 March 2025
Pregnenolone Sulfate Permeation at the Blood–Brain Barrier is Independent of OATP2B1—In Vivo and In Vitro Insights

In our study we report that OATP2B1 does not mediate pregnenolone sulfate transport across the blood–brain barrier in rats and in a human cell model, thus suggesting alternative mechanisms involved in pregnenolone sulfate brain uptake.